Standardization of diagnostic procedures is a continuous evaluation and optimization process.
The ELN establishes such procedures within networks of reference labs for leukemia diagnostics and pharmacokinetics across Europe.
One diagnostic standardization effort on a European scale is the EUTOS for CML public-private partnership (www.eutos.org).
Standardisation leads to improvement of patient care and enables personalized treatment options.
Standardization of BCR-ABL diagnostics is currently ongoing in 57 European laboratories in 24 countries.
Imatinib blood level testing is in progress in 28 reference laboratories in 14 countries.